日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The Diagnosis and Treatment of Stimulant-Related Emergencies

兴奋剂相关紧急情况的诊断和治疗

Fries, Alexa; Christ, Michael; Nickl, Hendrik; Spreer, Maik; Pilhatsch, Maximilian; Petzold, Johannes

Impact of Covid-19 pandemic on trajectories of patients with severe alcohol use disorder treated with disulfiram

新冠疫情对接受双硫仑治疗的重度酒精使用障碍患者病情发展轨迹的影响

Pilhatsch, Maximilian; Schallenberg, Max; Vogel-Blaschka, Diana; Treu, Ariana-Berenike; Petzold, Johannes; Zander, Lena; Spreer, Maik

Sustained abstinence after a methamphetamine-specific treatment program for pregnant and parenting women

孕妇和育儿妇女在接受甲基苯丙胺专项治疗项目后持续戒断

Pilhatsch, Maximilian; Körner, Fabienne; Spreer, Maik; Pietsch, Arvid; Fries, Alexa; Petzold, Johannes

Clinical and Treatment Characteristics of 3795 Adults Consecutively Hospitalized for Major Depressive Disorder in the OASIS-D Study

OASIS-D研究中3795名因重度抑郁症连续住院的成年人的临床和治疗特征

Nöhles, Viktor B; Bermpohl, Felix; Schoofs, Nikola; Bathe-Peters, Rouven; Hilpert, Nina; Dafsari, Forugh Salimi; Reif-Leonhard, Christine; Reif, Andreas; Schillo, Susanne; Arshad, Rabia Sana; Getty, Patricia; Falkai, Peter; Schüle, Cornelius; Wang, Elena; Adli, Mazda; Papenfuß, René; Meyer-Lindenberg, Andreas; Fritze, Stefan; Otte, Christian; Piber, Dominique; Graumann, Livia; Weyn-Banningh, Sebastian; Bauer, Michael; Lewitzka, Ute; Spreer, Maik; Clemens, Julia; Rubarth, Kerstin; Correll, Christoph U

Effectiveness of Disulfiram as Adjunct to Addiction-Focused Treatment for Persons With Severe Alcohol Use Disorder

双硫仑作为重度酒精使用障碍患者成瘾治疗辅助药物的有效性

Schallenberg, Max; Vogel-Blaschka, Diana; Spreer, Maik; Göstl, Julia; Petzold, Johannes; Pilhatsch, Maximilian

[Relapse prevention of bipolar disorders: a cluster analytical approach in a randomized controlled psychotherapy study]

[双相情感障碍复发预防:一项随机对照心理治疗研究中的聚类分析方法]

Stamm, Thomas J; Fiebig, J; Malley, G O; Sondergeld, L M; Treu, P; Bermpohl, F; Friedel, E; Hindi-Attar, G; Quinlivian, E; Schreiter, S; Wietzke, A; Ethofer, T; Fallgatter, A; Lang, I; Beck, E; Krisch, K; Kunze, I; Niebler, R; Zwick, J; Kraft, V; Lambert, M; Rohenkohl; Rühl, F; Bauer, M; Conell, J; Jurjanz, L; Ritter, D; Ritter, P; Spreer, M; Biere, S; Goldbach, N; Kittel-Schneider, S; Matura, S; Oertel, V; Reif, A; Falkenberg, I; Kircher, T; Kluge, I; Mehl, S; Poll, E; Adorjan, K; Heilbronner, M; Kálmán, J; Klöhn-Saghatolislam, F; Schulze, T G; Senner, F; Gruber, O; Heß, L; Trost, S; Werner, C; Wolter, S; Hautzinger, M

Impulsive suicide in methamphetamine intoxication and self-reported ADHD: a case report

甲基苯丙胺中毒和自述患有注意力缺陷多动障碍的冲动性自杀:病例报告

Schallenberg, Max; Pietsch, Jörg; Spreer, Maik; Pilhatsch, Maximilian; Petzold, Johannes

[Patient and quality characteristics in the treatment with disulfiram (Antabus) in the German "Network for Alcohol Aversive Pharmacotherapy"]

[德国“酒精厌恶疗法网络”中双硫仑(安他布斯)治疗的患者和质量特征]

Zimmermann, Ulrich S; Plickert, Clemens; Lüdecke, Christel; Stuppe, Markus; Rosenbeiger, Christian; Krisam, Yvonne; Link, Tobias; Keller, Jean; Bühler, Gero; Scholz-Hehn, Deborah; Havemann-Reinecke, Ursula; Wedekind, Dirk; Luderer, Mathias; Spreer, Maik

Using naltrexone to validate a human laboratory test system to screen new medications for alcoholism (TESMA)- a randomized clinical trial

使用纳曲酮验证用于筛选治疗酒精成瘾新药的人体实验室测试系统(TESMA)——一项随机临床试验

Spreer, Maik; Grählert, Xina; Klut, Ina-Maria; Al Hamdan, Feras; Sommer, Wolfgang H; Plawecki, Martin H; O'Connor, Sean; Böttcher, Michael; Sauer, Cathrin; Smolka, Michael N; Zimmermann, Ulrich S

Safety Profile and Complication Rates in Emergency Off-label Use of Tirofiban in Interventional Neuroradiology : An Observational Dual Center Study

介入神经放射学中紧急使用替罗非班的安全性及并发症发生率:一项双中心观察性研究

Brockmann, Carolin; Dillinger, Daniel; Mpotsaris, Anastasios; Spreer, Annette; Maus, Volker; Waldeck, Stephan; Othman, Ahmed E; Altmann, Sebastian; Ringel, Florian; Kerz, Thomas; Brockmann, Marc A